A new survey has been launched by the Hair Loss Priority Setting Partnership (PSP), looking at how we can improve the way we prevent, diagnose and treat hair loss. The Hair Loss PSP is steered by clinicians and patients from across the UK, as well as the British Hair and Nail Society, The James Lind Alliance and Alopecia UK.
Those currently experiencing, or treating people with, hair loss are encouraged to take part in the survey. The aim is to find out more about what the priorities should be for future diagnosis, prevention and treatment of hair loss, whatever the cause.
The last few years have seen some major breakthroughs in hair loss treatment. In 2013, low-level laser therapies became popular, with the ‘laser comb’ and iGrow helmet taking centre stage. These work by using low-level lasers to stimulate blood flow to the hair follicles, which can help to deliver nutrients to the follicles, keeping them strong and encouraging healthy growth.
The HairMax Lasercomb is the only FDA-cleared device for low-level laser therapy, and there’s significant evidence that it can help to prevent hair loss, when used as part of a combined hair loss treatment plan. The iGrow and other low-level laser therapy treatments like the Theradome helmet, claim to increase hair growth by up to 40% over a four month period – although again, these are most effective when used as part of a wider, bespoke hair loss treatment plan.
The end of Alopecia Areata?
In August 2014, scientists at Columbia University Medical Centre successfully reversed hair loss in three patients with Alopecia Areata, using a drug known as ruxolitinib. This medication is already used in the EU and USA to treat bone marrow conditions, and all three patients experienced dramatic regrowth in the months after treatment. Of course, further tests are needed and it’s not clear yet what the side effects of the drug could be, but this is an exciting breakthrough nevertheless.
New treatments for cancer
We also heard about new targeted genetic treatments for cancer, which targets only cancer cells. Current chemotherapy drugs can attack healthy cells as well as cancer cells, and chemotherapy hair loss is a side effect of treatment for many patients. These new treatments should mean that cancer-related hair loss becomes a thing of the past.
With the help of the Hair Loss PSP’s new survey, areas for improvement in the fields of prevention, diagnosis and treatment of hair loss can be identified, and if you have been affected by a hair loss condition, this is your chance to have your say. If you would like to add your thoughts to the survey, you can find it at: www.surveymonkey.com/s/hairlosspsp
The Belgravia Centre
The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.
|The Most Effective Treatments for Male Hair Loss||Belgravia’s Advice on the Most Well-Known Hair Loss Products||The Best Treatments for Women’s Hair Loss|